Institutional investors purchased a net $2.4 million shares of BGNE during the quarter ended March 2019, and now own 58.65% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 1.6 Million shares of Beigene Ltd
CAPITAL RESEARCH & MANAGEMENT CO... Bought 246.8 Thousand shares of Beigene Ltd